Although it was reported that CCNA2 is an AR-Vs specific or target gene in prostate cancer cells [41–43], our finding reveals that dihydrotestosterone increases the ARE occupancy by AR-FL in CCNA2 gene and cyclin A2 expression in AR-FL positive cells. The gene discussed is CCNA2; the disease is prostate carcinoma.